MagicMed Industries Inc has garnered quite a fan club. And it’s one that’s been willing to show the color of its money as investors recently got behind a US$1.6mln private placement.
The team is using this cash injection to “expedite and amplify” development of the MagicMed Psybrary. This is a library of new derivative molecules that are patentable
"The MagicMed Psybrary encompasses the patent portfolio and psychedelic derivative molecules that we offer as an acceleration platform to partner companies in this developing industry," said CEO Dr Joseph Tucker recently.
"Each derivative molecule in the Psybrary is a potential patented drug development candidate for our future biotech and pharmaceutical partners."
Joseph is joining us on October 7 at 1pm EST for our Virtual One2One event, which is a psychedelics showcase.
The keynote speaker is one of the leading investors in this emerging and exciting space, Henri Sant-Cassia, founding partner of The Conscious Fund, the ethical VC for plant powered medicines.
About the event:
- Ours is an audience of astute high net worth investors, fund managers, private client brokers and analysts
- We look beyond the numbers and meet the people creating the value for shareholders
- Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
- You can watch the event afterwards on our YouTube channel